Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

Felicita Andreotti; Bianca Rocca; Steen Husted; Ramzi A Ajjan; Jurrien ten Berg; Marco Cattaneo; Jean-Philippe Collet; Raffaele De Caterina; Keith A A Fox; Sigrun Halvorsen; Kurt Huber; Elaine M Hylek; Gregory Y H Lip; Gilles Montalescot; Joao Morais; Carlo Patrono; Freek W A Verheugt; Lars Wallentin; Thomas W Weiss; Robert F Storey; ESC Thrombosis Working Group

doi:10.1093/eurheartj/ehv304

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

Eur Heart J. 2015 Dec 7;36(46):3238-49. doi: 10.1093/eurheartj/ehv304. Epub 2015 Jul 9.

Authors

Felicita Andreotti¹, Bianca Rocca², Steen Husted³, Ramzi A Ajjan⁴, Jurrien ten Berg⁵, Marco Cattaneo⁶, Jean-Philippe Collet⁷, Raffaele De Caterina⁸, Keith A A Fox⁹, Sigrun Halvorsen¹⁰, Kurt Huber¹¹, Elaine M Hylek¹², Gregory Y H Lip¹³, Gilles Montalescot¹⁴, Joao Morais¹⁵, Carlo Patrono², Freek W A Verheugt¹⁶, Lars Wallentin¹⁷, Thomas W Weiss¹¹, Robert F Storey¹⁸; ESC Thrombosis Working Group

Affiliations

¹ Department of Cardiovascular Science, Catholic University Medical School, Largo F Vito 1, Rome 00168, Italy felicita.andreotti@iol.it.
² Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
³ Medical Department, Region Hospital West, Herning/Holstebro, Denmark.
⁴ Division of Cardiovascular and Diabetes Research, The LIGHT Laboratories, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Leeds, UK.
⁵ Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
⁶ Medicina 3, Ospedale San Paolo - Dipartimento di SCienze della Salute, UNiversità degli Studi di Milano, Milan, Italy.
⁷ Institut de Cardiologie, INSERM UMRS 1166, Allies in Cardiovascular Trials Initiatives and Organized Networks Group, Pitié-Salpêtrière Hospital (Assistance Publique-Hôpitaux de Paris), Université Pierre et Marie Curie, Paris, France.
⁸ Department of Cardiology, 'G. d'Annunzio' University - Ospedale SS. Annunziata, Chieti, Italy.
⁹ Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
¹⁰ Department of Cardiology B, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
¹¹ 3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Montleartstrasse 37, Vienna A-1160, Austria.
¹² Department of Medicine, Boston University School of Medicine-Boston Medical Center, Boston, MA, USA.
¹³ University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
¹⁴ Institut de Cardiologie, INSERM UMRS 1166, Pitié-Salpêtrière Hospital (Assistance Publique-Hôpitaux de Paris), Université Pierre et Marie Curie, Paris, France.
¹⁵ Department of Cardiology, Hospital de Santo André, Leiria, Portugal.
¹⁶ Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, the Netherlands.
¹⁷ Uppsala Clinical Research Center and Department of Medical Sciences (Cardiology), Uppsala University, Uppsala, Sweden.
¹⁸ Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.

PMID: 26163482
DOI: 10.1093/eurheartj/ehv304

No abstract available

Publication types

Review

MeSH terms

Administration, Oral
Age Factors
Anticoagulants / therapeutic use
Blood Coagulation Factors / metabolism
Fibrinolytic Agents / pharmacokinetics
Fibrinolytic Agents / therapeutic use*
Forecasting
Hemorrhage / prevention & control
Humans
Infusions, Parenteral
Myocardial Infarction / drug therapy
Platelet Aggregation Inhibitors / administration & dosage
Pulmonary Embolism / drug therapy
Purinergic P2Y Receptor Antagonists / administration & dosage
Thrombosis / drug therapy*

Substances

Anticoagulants
Blood Coagulation Factors
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists

Grants and funding

PG/09/020/26305/BHF_/British Heart Foundation/United Kingdom